Evidence map›Paper›PMID 36823638›Full record

ReviewJournal of cardiothoracic surgery2023

Surgical considerations in the resection of solitary fibrous tumors of the pleura.

Hana Ajouz, Amir Humza Sohail, Hassan Hashmi, Myriam Martinez Aguilar, Sabrina Daoui, Miltiadis Tembelis, Muhammad Aziz, Tirajeh Zohourian, Collin E M Brathwaite, Robert J Cerfolio

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cardiothoracic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Solitary Fibrous Tumor of the Forehead.Indian dermatology online journal · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Application ofFrontiers in medicine · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Hana AjouzDepartment of Surgery, University of Miami Health System, Miami, FL, USA.
Amir Humza SohailDepartment of Surgery, New York University Langone Health, New York, USA.
Hassan HashmiDepartment of Surgery, LeHigh Valley Health Network, Allentown, PA, USA.
Myriam Martinez AguilarDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Sabrina DaouiNew York University Long Island School of Medicine, Mineola, NY, USA. Sabrina.daoui@nyulangone.org.
Miltiadis TembelisDepartment of Radiology, New York University Langone Health, New York, USA.
Muhammad AzizDepartment of Medicine, University of Toledo Medical Center, Toledo, OH, USA.
Tirajeh ZohourianDepartment of Surgery, New York University Langone Health, New York, USA.
Collin E M BrathwaiteDepartment of Surgery, New York University Langone Health, New York, USA.
Robert J CerfolioDepartment of Surgery, New York University Langone Health, New York, USA.
NYU Langone Health · USLehigh Valley Hospital-Pocono · USMayo Clinic in Arizona · USNew York University · USUniversity of Miami Health System · USUniversity of Toledo Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solitary fibrous tumors (SFTs) are rare mesenchymal pleural neoplasms with an overall good prognosis and low recurrence rate if completely resected and if degree of differentiation is favorable. Within the last decade, advances in research have led to more reliable methods of differentiating SFTs from other soft tissue tumors. Historically, several markers were used to distinguish SFTs from similar tumors, but these markers had poor specificity. Recent evidence showed NAB2-STAT6 fusion gene to be a distinct feature of SFTs with 100% specificity and sensitivity. Surgical resection, with an emphasis on obtaining negative margins, is the mainstay of treatment for SFTs. Preoperative planning with detailed imaging is imperative to delineate the extent of disease and vascular supply. One important radiologic distinction to aid delineation of a pleural-based tumor compared to a pulmonary parenchymal-based tumor is the angle that the tumor forms with the chest wall, which is obtuse for a pleural-based tumor, and acute for tumors of the lung parenchyma. Often, preoperative tissue diagnosis is not available, and surgery is both diagnostic and curative. Intraoperatively, emphasis should be on complete resection with negative margins. SFTs are resected via several approaches: thoracotomy, sternotomy with the option of hemi-clamshell extension, video-assisted thoracoscopic surgery, and robotic approach, which is increasingly being used and is our preference. We recommend a minimally invasive approach for most lesions, and have resected SFTs of the pleura that are up to 12 cm with the robotic approach. However, the current literature often cites 5 cm as the cut off for an open thoracotomy. Nevertheless, even with larger tumors, a minimally invasive robotic approach is our preference and practice. For giant SFTs (> 20 cm), an open approach may be preferable. Multiple thoracotomies and rib resection may be required to gain adequate exposure and ensure complete resection in these tumors. However, it is noteworthy that most of these tumors have a soft consistency and thus, once bagged, can easily be removed minimally invasively, and thus minimally invasive approach should not be completely ruled out. Recurrence in SFTs usually results from incomplete resection and redo surgery may portend a favorable prognosis.

Indexed as

Pleural NeoplasmsSevere Fever with Thrombocytopenia SyndromeSolitary Fibrous TumorsHumansPleuraPrognosisLung tumorSolitary fibrous tumorSurgeryVATS

Identifiers

PMID36823638
PMCPMC9951522
OpenAlexW4321748899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.